The novel role of platelet-activating factor in protecting mice against lipopolysaccharide-induced endotoxic shock

PLoS One. 2009 Aug 4;4(8):e6503. doi: 10.1371/journal.pone.0006503.

Abstract

Background: Platelet-activating factor (PAF) has been long believed to be associated with many pathophysiological processes during septic shock. Here we present novel activities for PAF in protecting mice against LPS-mediated endotoxic shock.

Principal findings: In vivo PAF treatment immediately after LPS challenge markedly improved the survival rate against mortality from endotoxic shock. Administration of PAF prominently attenuated LPS-induced organ injury, including profound hypotension, excessive polymorphonuclear neutrophil infiltration, and severe multiple organ failure. In addition, PAF treatment protects against LPS-induced lymphocytes apoptosis. These protective effects of PAF was correlated with significantly decreases in the production of the inflammatory mediators such as TNF-alpha, IL-1beta, IL-12, and IFN-gamma, while increasing production of the anti-inflammatory cytokine IL-10 in vivo and in vitro.

Conclusions: Taken together, these results suggest that PAF may protect mice against endotoxic shock via a complex mechanism involving modulation of inflammatory and anti-inflammatory mediators.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apoptosis / drug effects
  • Inflammation Mediators / metabolism
  • Lipopolysaccharides / toxicity*
  • Lymphocytes / drug effects
  • Mice
  • Platelet Activating Factor / administration & dosage
  • Platelet Activating Factor / pharmacology*
  • Shock, Septic / metabolism
  • Shock, Septic / prevention & control*

Substances

  • Inflammation Mediators
  • Lipopolysaccharides
  • Platelet Activating Factor